Tragic Case of Rare Amoeba Infection in Texas

On May 29, 2025, health officials confirmed the death of a 71-year-old woman in Texas due to an infection from the “brain-eating amoeba,” Naegleria fowleri. She reportedly rinsed her sinuses with tap water from an RV while at a campground near Austin. Just four days later, she became ill. Despite extensive treatment, she suffered seizures and passed away eight days after her symptoms started.

Interestingly, while no amoeba was detected in subsequent water samples from the site, investigators noted poor water quality and lack of proper disinfection. This incident echoes a previous summer when three cases of Naegleria fowleri were reported in Israel, including that of a 10-year-old boy, all linked to warm freshwater exposure in the Sea of Galilee region. This led to the temporary closure of Gai Beach Water Park as a cautionary measure.

The infection causes a severe illness known as Primary Amoebic Meningoencephalitis (PAM), which is extremely rare but highly lethal. Each year, there are usually only around three cases in the U.S., with almost all victims succumbing to the disease. Historical data from 1962 to 2021 indicate a survival rate of just over 2%, with only four out of 154 patients known to have lived after an infection.

Patients typically show symptoms resembling bacterial meningitis. The early signs include intense headaches, fever, nausea, and vomiting, followed by neck stiffness, a classic sign of meningitis. An unusual symptom specific to PAM is the loss of smell. Neurological symptoms then escalate rapidly, potentially leading to confusion, light sensitivity, hallucinations, and ultimately coma within days.

It’s worth noting that the rarity of PAM can lead to misdiagnosis, especially since its symptoms mimic those of bacterial meningitis, which is far more common. In one recent Israeli case, prompt diagnosis was made by an infectious disease expert who linked the patient’s symptoms to recent freshwater exposure.

Understanding Naegleria fowleri

Despite its alarming nickname, Naegleria fowleri doesn’t usually reside in humans. Instead, it is typically found in warm freshwater and soil globally. This single-celled organism thrives in warm conditions, existing mainly in its amoeba form when in freshwater, where it feeds on bacteria and other microorganisms.

Under less favorable circumstances, the amoeba can switch to a flagellate stage to seek a better environment, and if conditions worsen, it can form a cyst—an inactive and resilient form that can survive harsh environments for extended periods. This characteristic is crucial, allowing it to emerge once conditions become hospitable again.

Naegleria fowleri can be found almost everywhere except Antarctica, predominantly in warm freshwater sources like ponds and improperly disinfected pools. It thrives in temperatures between 35°C and 46°C (95–115°F), making summer months particularly risky for infections.

Infection is rare and usually occurs when water contaminated with the amoeba enters the nasal cavity, often during activities like swimming. Importantly, it cannot be contracted through drinking contaminated water or via person-to-person contact. However, using untreated water for sinus rinsing can lead to infection.

Upon entering the nasal cavity, the amoeba attaches to the mucosa and travels through the olfactory nerve toward the brain, causing severe inflammation—it can be particularly harmful since the skull does not afford room for swelling, leading to fatal outcomes.

Symptoms typically show up within a week of infection, with death usually occurring about ten days after onset. The speed of disease progression is alarming, as many cases may not be identified until too late or may be misdiagnosed, complicating conditions.

Currently, treatments specifically targeting Naegleria fowleri are limited, although some protocols do exist. The drugs involved have shown effectiveness in lab studies, but unfortunately, no clinically validated treatments are widely accepted. Research continues into better therapies, especially as more cases arise globally.

Many times, Naegleria fowleri infections can be challenging to treat because the blood-brain barrier restricts the entry of many drugs. Supportive care is also vital in managing inflammation and pressure within the brain—approaches like cooling the body temperature to alleviate swelling can sometimes help too.

The overall picture is troubling, as the recent increase in PAM cases seems linked to rising temperatures and greater human activity in water, particularly in places where the amoeba may thrive. Over time, climate change appears to be expanding the range of Naegleria fowleri, as shown by recent cases in traditionally cooler areas.

To minimize risk, maintaining proper disinfectant systems in pools and ensuring safe drinking water is critical. Public awareness campaigns have successfully reduced infections in some regions, emphasizing that while the threat exists, relaxation and enjoyment of water activities can continue with necessary precautions.

All in all, while infections are extremely rare, they are severe when they occur, leading to calls for awareness around how simple preventive measures can help in ensuring safety during recreation in warm waters.